(2R,6S)-6-(benzyloxymethyl)-4-(tert-butoxycarbonyl)morpholine-2-carboxylic acid is a chiral morpholine derivative featuring a carboxylic acid group, a tert-butoxycarbonyl (Boc) protected amine, and a benzyloxymethyl side chain. Its specific stereochemistry ((2R,6S)) is a key structural feature. This compound is primarily utilized as a sophisticated chiral building block in pharmaceutical research and development. It serves as a crucial intermediate in the synthesis of complex drug candidates, particularly those targeting protease enzymes. The morpholine core is a privileged scaffold in medicinal chemistry, often found in molecules with diverse biological activities. The Boc protecting group allows for selective deprotection and further functionalization during multi-step synthetic sequences. Its defined stereochemistry makes it valuable for constructing molecules with specific three-dimensional configurations required for high target affinity and selectivity. It is a non-natural, synthetic intermediate supplied for research purposes in drug discovery programs.